Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH: Hypertriglyceridemia and its pharmacologic treatment among US adults. Arch Intern Med. 2009, 169 (6): 572-578. 10.1001/archinternmed.2008.599.
Article
CAS
PubMed
Google Scholar
Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V: Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation. 2007, 115 (4): 450-458. 10.1161/CIRCULATIONAHA.106.637793.
Article
CAS
PubMed
Google Scholar
Hokanson JE, Austin MA: Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996, 3 (2): 213-219. 10.1097/00043798-199604000-00014.
Article
CAS
PubMed
Google Scholar
Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, Whitlock G, Woodward M: Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation. 2004, 110 (17): 2678-2686.
Article
CAS
PubMed
Google Scholar
Toskes PP: Hyperlipidemic pancreatitis. Gastroenterol Clin North Am. 1990, 19 (4): 783-791.
CAS
PubMed
Google Scholar
Brunzell JD, Schrott HG: The interaction of familial and secondary causes of hypertriglyceridemia: role in pancreatitis. Trans Assoc Am Physicians. 1973, 86: 245-254.
CAS
PubMed
Google Scholar
Familial lipoprotein lipase deficiency, ApoC-II deficiency, and hepatic lipase deficiency. The Metabolic Basis of Inherited Disease. Edited by: Scriver C, Beaudet A, Sly W, Valle D, Brunzell J, Deeb SI. 2001, New York: McGraw-Hill, 2789-2816. 8
Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6 (7): e1000097-10.1371/journal.pmed.1000097.
Article
PubMed
PubMed Central
Google Scholar
Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute.
Swiglo BA, Murad MH, Schunemann HJ, Kunz R, Vigersky RA, Guyatt GH, Montori VM: A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab. 2008, 93 (3): 666-673.
Article
CAS
PubMed
Google Scholar
DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7 (3): 177-188. 10.1016/0197-2456(86)90046-2.
Article
CAS
PubMed
Google Scholar
Egger M, Davey Smith G, Schneider M, Minder Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315 (7109): 629-634. 10.1136/bmj.315.7109.629.
Article
CAS
PubMed
PubMed Central
Google Scholar
Acarturk E, Cayli M, Akpinar O, Attila G, Demir M: Relation between age and gender differences in plasma triglyceride concentrations and coronary artery disease in Southern Turkey. Clin Chim Acta. 2004, 339 (1-2): 123-128. 10.1016/j.cccn.2003.10.001.
Article
CAS
PubMed
Google Scholar
Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM: Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007, 298 (3): 309-316. 10.1001/jama.298.3.309.
Article
CAS
PubMed
Google Scholar
Barrett-Connor E, Khaw KT: Borderline fasting hypertriglyceridemia: absence of excess risk of all-cause and cardiovascular disease mortality in healthy men without hypercholesterolemia. Prev Med. 1987, 16 (1): 1-8. 10.1016/0091-7435(87)90001-6.
Article
CAS
PubMed
Google Scholar
Bass KM, Newschaffer CJ, Klag MJ, Bush TL: Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med. 1993, 153 (19): 2209-2216. 10.1001/archinte.1993.00410190045006.
Article
CAS
PubMed
Google Scholar
Bonaventure A, Kurth T, Pico F, Barberger-Gateau P, Ritchie K, Stapf C, Tzourio C: Triglycerides and risk of hemorrhagic stroke vs. ischemic vascular events: the three-city study. Atherosclerosis. 2010, 210 (1): 243-248. 10.1016/j.atherosclerosis.2009.10.043.
Article
CAS
PubMed
Google Scholar
Carlson LA, Rosenhamer G: Reduction of mortality in the Stockholm ischaemic heart disease secondary prevention study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand. 1988, 223 (5): 405-418.
Article
CAS
PubMed
Google Scholar
Chan WB, Tong PC, Chow CC, So WY, Ng MC, Ma RC, Osaki R, Cockram CS, Chan JC: Triglyceride predicts cardiovascular mortality and its relationship with glycaemia and obesity in Chinese type 2 diabetic patients. Diabetes Metab Res Rev. 2005, 21 (2): 183-188. 10.1002/dmrr.497.
Article
CAS
PubMed
Google Scholar
Chester M, Chen L, Kaski JC: Identification of patients at high risk for adverse coronary events while awaiting routine coronary angioplasty. Br Heart J. 1995, 73 (3): 216-222. 10.1136/hrt.73.3.216.
Article
CAS
PubMed
PubMed Central
Google Scholar
Czernichow S, Bruckert E, Bertrais S, Galan P, Hercberg S, Oppert JM: Hypertriglyceridemic waist and 7.5-year prospective risk of cardiovascular disease in asymptomatic middle-aged men. Int J Obes (Lond). 2007, 31 (5): 791-796.
CAS
Google Scholar
Drexel H, Aczel S, Marte T, Benzer W, Langer P, Moll W, Saely CH: Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol?. Diabetes Care. 2005, 28 (1): 101-107. 10.2337/diacare.28.1.101.
Article
CAS
PubMed
Google Scholar
Eberly LE, Stamler J, Neaton JD: Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Arch Intern Med. 2003, 163 (9): 1077-1083. 10.1001/archinte.163.9.1077.
Article
PubMed
Google Scholar
Egger M, Smith GD, Pfluger D, Altpeter E, Elwood PC: Triglyceride as a risk factor for ischaemic heart disease in British men: effect of adjusting for measurement error. Atherosclerosis. 1999, 143 (2): 275-284. 10.1016/S0021-9150(98)00300-1.
Article
CAS
PubMed
Google Scholar
Ellingsen I, Hjermann I, Abdelnoor M, Hjerkinn EM, Tonstad S: Dietary and antismoking advice and ischemic heart disease mortality in men with normal or high fasting triacylglycerol concentrations: a 23-y follow-up study. Am J Clin Nutr. 2003, 78 (5): 935-940.
CAS
PubMed
Google Scholar
Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE: Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 1997, 96 (8): 2520-2525.
Article
CAS
PubMed
Google Scholar
Goldberg RJ, Urowitz MB, Ibanez D, Nikpour M, Gladman DD: Risk factors for development of coronary artery disease in women with systemic lupus erythematosus. J Rheumatol. 2009, 36 (11): 2454-2461. 10.3899/jrheum.090011.
Article
CAS
PubMed
Google Scholar
Habib AN, Baird BC, Leypoldt JK, Cheung AK, Goldfarb-Rumyantzev AS: The association of lipid levels with mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant. 2006, 21 (10): 2881-2892. 10.1093/ndt/gfl272.
Article
PubMed
Google Scholar
Haim M, Benderly M, Brunner D, Behar S, Graff E, Reicher-Reiss H, Goldbourt U: Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) registry. Circulation. 1999, 100 (5): 475-482.
Article
CAS
PubMed
Google Scholar
Hoogeveen RC, Gambhir JK, Gambhir DS, Kimball KT, Ghazzaly K, Gaubatz JW, Vaduganathan M, Rao RS, Koschinsky M, Morrisett JD: Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res. 2001, 42 (4): 631-638.
CAS
PubMed
Google Scholar
Jonsdottir LS, Sigfusson N, Guonason V, Sigvaldason H, Thorgeirsson G: Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik study. J Cardiovasc Risk. 2002, 9 (2): 67-76. 10.1097/00043798-200204000-00001.
Article
PubMed
Google Scholar
Lamarche B, Despres JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ: Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular study). Am J Cardiol. 1995, 75 (17): 1189-1195. 10.1016/S0002-9149(99)80760-7.
Article
CAS
PubMed
Google Scholar
Lloret Linares C, Pelletier AL, Czernichow S, Vergnaud AC, Bonnefont-Rousselot D, Levy P, Ruszniewski P, Bruckert E: Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia. Pancreas. 2008, 37 (1): 12-13.
Google Scholar
Lu W, Resnick HE, Jablonski KA, Jones KL, Jain AK, Howard WMJ, Robbins DC, Howard BV: Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: The strong heart study. Diabetes Care. 2003, 26 (1): 16-23. 10.2337/diacare.26.1.16.
Article
PubMed
Google Scholar
Malone DC, Boudreau DM, Nichols GA, Raebel MA, Fishman PA, Feldstein AC, Ben-Joseph RH, Okamoto LJ, Boscoe AN, Magid DJ: Association of cardiometabolic risk factors and prevalent cardiovascular events. Metab Syndr Relat Disord. 2009, 7 (6): 585-593. 10.1089/met.2009.0033.
Article
PubMed
Google Scholar
Mazza A, Tikhonoff V, Schiavon L, Casiglia E: Triglycerides + high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the ELderly. Intern Med J. 2005, 35 (10): 604-610. 10.1111/j.1445-5994.2005.00940.x.
Article
CAS
PubMed
Google Scholar
Mora S, Rifai N, Buring JE, Ridker PM: Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation. 2008, 118 (10): 993-1001. 10.1161/CIRCULATIONAHA.108.777334.
Article
CAS
PubMed
PubMed Central
Google Scholar
Noda H, Maruyama K, Iso H, Dohi S, Terai T, Fujioka S, Goto K, Horie S, Nakano S, Hirobe K: Prediction of myocardial infarction using coronary risk scores among Japanese male workers: 3M study. J Atheroscler Thromb. 2010, 17 (5): 452-459. 10.5551/jat.3277.
Article
PubMed
Google Scholar
Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med. 1999, 341 (6): 410-418. 10.1056/NEJM199908053410604.
Article
CAS
PubMed
Google Scholar
Samuelsson O, Hedner T, Persson B, Andersson O, Berglund G, Wilhelmesen L: The role of diabetes mellitus and hypertriglyceridaemia as coronary risk factors in treated hypertension: 15 years of follow-up of antihypertensive treatment in middle-aged men in the Primary Prevention Trial in Goteborg, Sweden. J Intern Med. 1994, 235 (3): 217-227. 10.1111/j.1365-2796.1994.tb01063.x.
Article
CAS
PubMed
Google Scholar
Schupf N, Costa R, Luchsinger J, Tang MX, Lee JH, Mayeux R: Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatr Soc. 2005, 53 (2): 219-226. 10.1111/j.1532-5415.2005.53106.x.
Article
PubMed
Google Scholar
Sprecher DL, Pearce GL, Park EM, Pashkow FJ, Hoogwerf BJ: Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis. Diabetes Care. 2000, 23 (11): 1648-1653. 10.2337/diacare.23.11.1648.
Article
CAS
PubMed
Google Scholar
Tanko LB, Bagger YZ, Qin G, Alexandersen P, Larsen PJ, Christiansen C: Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation. 2005, 111 (15): 1883-1890. 10.1161/01.CIR.0000161801.65408.8D.
Article
CAS
PubMed
Google Scholar
Tsai SP, Wen CP, Chan HT, Chiang PH, Tsai MK, Cheng TY: The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality. Diabetes Res Clin Pract. 2008, 82 (1): 148-156. 10.1016/j.diabres.2008.07.016.
Article
PubMed
Google Scholar
Upmeier E, Lavonius S, Lehtonen A, Viitanen M, Isoaho H, Arve S: Serum lipids and their association with mortality in the elderly: A prospective cohort study. Aging Clin Exp Res. 2009, 21 (6): 424-430.
Article
CAS
PubMed
Google Scholar
Valdivielso P, Sanchez-Chaparro MA, Calvo-Bonacho E, Cabrera-Sierra M, Sainz-Gutierrez JC, Fernandez-Labandera C, Fernandez-Meseguer A, Quevedo-Aguado L, Moraga MR, Galvez-Moraleda A: Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: results of the ICARIA study. Atherosclerosis. 2009, 207 (2): 573-578. 10.1016/j.atherosclerosis.2009.05.024.
Article
CAS
PubMed
Google Scholar
Weir CJ, Sattar N, Walters MR, Lees KR: Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovasc Dis. 2003, 16 (1): 76-82. 10.1159/000070119.
Article
CAS
PubMed
Google Scholar
Furukawa TA, Watanabe N, Omori IM, Montori VM, Guyatt GH: Association between unreported outcomes and effect size estimates in Cochrane meta-analyses. JAMA. 2007, 297 (5): 468-470.
Article
CAS
PubMed
Google Scholar
Labreuche J, Deplanque D, Touboul PJ, Bruckert E, Amarenco P: Association between change in plasma triglyceride levels and risk of stroke and carotid atherosclerosis: systematic review and meta-regression analysis. Atherosclerosis. 2010, 212 (1): 9-15. 10.1016/j.atherosclerosis.2010.02.011.
Article
CAS
PubMed
Google Scholar
Gandhi GY, Murad MH, Fujiyoshi A, Mullan RJ, Flynn DN, Elamin MB, Swiglo BA, Isley WL, Guyatt GH, Montori VM: Patient-important outcomes in registered diabetes trials. JAMA. 2008, 299 (21): 2543-2549. 10.1001/jama.299.21.2543.
Article
CAS
PubMed
Google Scholar
Bruckert E, Labreuche J, Deplanque D, Touboul PJ, Amarenco P: Fibrates effect on cardiovascular risk is greater in patients with high triglyceride levels or atherogenic dyslipidemia profile: a systematic review and meta-analysis. J Cardiovasc Pharmacol. 2011, 57 (2): 267-272. 10.1097/FJC.0b013e318202709f.
Article
CAS
PubMed
Google Scholar
Loomba RS, Arora R: Prevention of cardiovascular disease utilizing fibrates-a pooled meta-analysis. Am J Ther. 2010, 17 (6): e182-e188. 10.1097/MJT.0b013e3181dcf72b.
Article
PubMed
Google Scholar
Jun M, Foote C, Lv J, Neal B, Patel A, Nicholls SJ, Grobbee DE, Cass A, Chalmers J, Perkovic V: Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet. 2010, 375 (9729): 1875-1884. 10.1016/S0140-6736(10)60656-3.
Article
CAS
PubMed
Google Scholar
Lee M, Saver JL, Towfighi A, Chow J, Ovbiagele B: Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis. Atherosclerosis. 2011
Google Scholar
Bruckert E, Labreuche J, Amarenco P: Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis. Atherosclerosis. 2010, 210 (2): 353-361. 10.1016/j.atherosclerosis.2009.12.023.
Article
CAS
PubMed
Google Scholar
Duggal JK, Singh M, Attri N, Singh PP, Ahmed N, Pahwa S, Molnar J, Singh S, Khosla S, Arora R: Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease. J Cardiovasc Pharmacol Ther. 2010, 15 (2): 158-166. 10.1177/1074248410361337.
Article
CAS
PubMed
Google Scholar
Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH: Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010, 363 (3): 233-244.
Article
PubMed
Google Scholar
AIM-HIGH Investigators: The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH). Am Heart J. 2011, 161 (3): 471-477. e472
Article
Google Scholar